Tuberculosis Vaccine
Lentinan stimulates host defense against tuberculosis infection
Published in Vaccine Weekly, November 12th, 2003
According to recent research from Bulgaria, the "protective effects of Lentinan (Ajinomoto, Japan) against Mycobacterium tuberculosis infection were studied by in vitro and in vivo mouse models."
"The effectiveness of Lentinan administrated intraperitoneally (i.p.) before infection at a dose of 1 mg/kg three times at two-day intervals was monitored in vivo by several parameters (body temperature; spleen weight; CFU counts of M. tuberculosis in spleen, liver and lung; and histomorphological observations)," explained N. Markova and coauthors...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-11-12)
More Articles from Vaccine Weekly
- Streptococcal Vaccine
Group A streptococcal C5a peptidase is effective vaccine antigen - Vaccine Delivery
Delivery of antigens onto bare skin may provide painless vaccination - Encephalitis Vaccine
Vaccine candidate for Venezuelan equine encephalitis identified - HIV/AIDS Vaccine
Mucosal delivery of HIV-1 Tat protein elicits strong immune response - Malaria Vaccine
Plasmodium vivax adapted to Aotus monkeys aids malaria vaccine development - Vaccine Development
Human T-cells recognize N-terminally Fmoc-modified peptide - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
